References
- Grienke U, Schmidtke M, von Grafenstein S, Kirchmair J, Liedl KR, Rollinger JM. 2012. Influenza neuraminidase: a druggable target for natural products. Nat Prod Rep. 29(1):11–36.
- Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Cohen C, Gran JM, Schanzer D, Cowling BJ, et al. 2018. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 391(10127):1285–1300.
- Jones JC, Marathe BM, Lerner C, Kreis L, Gasser R, Pascua PNQ, Najera I, Govorkova EA. 2016. A novel endonuclease inhibitor exhibits broad-spectrum anti-influenza virus activity in vitro. Antimicrob Agents Chemother. 60(9):5504–5514.
- Miki K, Nagai T, Suzuki K, Tsujimura R, Koyama K, Kinoshita K, Furuhata K, Yamada H, Takahashi K. 2007. Anti-influenza virus activity of biflavonoids. Bioorg Med Chem Lett. 17(3):772–775.
- Silva GL, Chai H, Gupta MP, Farnsworth NR, Cordell GA, Pezzuto JM, Beecher CWW, Douglas Kinghorn A. 1995. Cytotoxic biflavonoids from Selaginella willdenowii. Phytochemistry. 40(1):129–134.
- Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. 2003. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 289(2):179–186.